Regulation of HHLA2 expression in renal cell carcinoma and myeloid cells

被引：0
|
作者：
Shigemura, Tomonari [1 ]
Perrot, Nahuel [2 ]
Huang, Zimo [2 ]
Sheshdeh, Aseman Bagheri [3 ]
El Ahmar, Nourhan [3 ]
McDermott, David [2 ]
Signoretti, Sabina
Freeman, Gordon [1 ]
Mahoney, Kathleen [4 ]
机构：
[1] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[4] Harvard Med Sch, Dana Farber Canc Inst, Beth Israel Deaconess Med Ctr, Boston, MA USA
来源：
CANCER RESEARCH | 2023年 / 83卷 / 16期
关键词：
D O I：
10.1158/1538-7445.KIDNEY23-A005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A005
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Regulation of HHLA2 expression in kidney cancer and myeloid cells
    Shigemura, Tomonari
    Perrot, Nahuel
    Huang, Zimo
    Bhatt, Rupal S.
    Sheshdeh, Aseman Bagheri
    Ahmar, Nourhan El
    Ghandour, Fatme
    Signoretti, Sabina
    Mcdermott, David F.
    Freeman, Gordon J.
    Mahoney, Kathleen M.
    BMC CANCER, 2023, 23 (01)
  • [2] Regulation of HHLA2 expression in kidney cancer and myeloid cells
    Tomonari Shigemura
    Nahuel Perrot
    Zimo Huang
    Rupal S. Bhatt
    Aseman Bagheri Sheshdeh
    Nourhan El Ahmar
    Fatme Ghandour
    Sabina Signoretti
    David F. McDermott
    Gordon J. Freeman
    Kathleen M. Mahoney
    BMC Cancer, 23
  • [3] HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma
    Xu, Yituo
    Huang, Zhijie
    Yu, Xingjuan
    Li, Zhixiong
    Zheng, Limin
    Xu, Jing
    BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 329 - 341
  • [4] Over-Expression and Prognostic Significance of HHLA2, a New Immune Checkpoint Molecule, in Human Clear Cell Renal Cell Carcinoma
    Zhang, Zhen
    Liu, Jinyan
    Zhang, Chaoqi
    Li, Feng
    Li, Lifeng
    Wang, Dan
    Chand, Damini
    Guan, Fangxia
    Zang, Xingxing
    Zhang, Yi
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [5] Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
    Chen, Lujun
    Zhu, Dawei
    Feng, Jun
    Zhou, You
    Wang, Qi
    Feng, Huijing
    Zhang, Junping
    Jiang, Jingting
    CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [6] Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
    Chen, L.
    Jiang, J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1592 - 1592
  • [7] Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
    Lujun Chen
    Dawei Zhu
    Jun Feng
    You Zhou
    Qi Wang
    Huijing Feng
    Junping Zhang
    Jingting Jiang
    Cancer Cell International, 19
  • [8] HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma
    Zhou, Qiang-Hua
    Li, Kai-Wen
    Chen, Xu
    He, Hai-Xia
    Peng, Sheng-Meng
    Peng, Shi-Rong
    Wang, Qiong
    Li, Ze-An
    Tao, Yi-Ran
    Cai, Wen-Li
    Liu, Ran-Yi
    Huang, Hai
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [9] High expression of HHLA2 predicts poor prognosis in medullary thyroid carcinoma
    Niu, Yongzhi
    Wang, Wei
    Jiang, Xiaodan
    Huang, Yichuan
    Yan, Shu
    Jiang, Yan
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (07) : 751 - 757
  • [10] EXPRESSION OF HHLA2 IN CARDIA CARCINOMA AND ITS CORRELATION WITH CLINICOPATHOLOGICAL FEATURES AND PROGNOSIS
    Zheng, Xiaodong
    Zhang, Weimin
    Yue, Guangchen
    Wei, Xudong
    Nie, Shiwei
    ACTA MEDICA MEDITERRANEA, 2022, 38 (05): : 3251 - 3255
12345